These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

298 related items for PubMed ID: 9543133

  • 1. Comparison of effects of tamoxifen and toremifene on bone biochemistry and bone mineral density in postmenopausal breast cancer patients.
    Marttunen MB, Hietanen P, Tiitinen A, Ylikorkala O.
    J Clin Endocrinol Metab; 1998 Apr; 83(4):1158-62. PubMed ID: 9543133
    [Abstract] [Full Text] [Related]

  • 2. Effects of tamoxifen and toremifene on urinary excretion of pyridinoline and deoxypyridinoline and bone density in postmenopausal patients with breast cancer.
    Marttunen MB, Hietanen P, Titinen A, Roth HJ, Viinikka L, Ylikorkala O.
    Calcif Tissue Int; 1999 Nov; 65(5):365-8. PubMed ID: 10541761
    [Abstract] [Full Text] [Related]

  • 3. Changes in bone mineral density during and after 3 years' use of tamoxifen or toremifene.
    Tiitinen A, Nikander E, Hietanen P, Metsä-Heikkilä M, Ylikorkala O.
    Maturitas; 2004 Jul 15; 48(3):321-7. PubMed ID: 15207898
    [Abstract] [Full Text] [Related]

  • 4. Bone mineral density and bone turnover before and after surgical cure of Cushing's syndrome.
    Hermus AR, Smals AG, Swinkels LM, Huysmans DA, Pieters GF, Sweep CF, Corstens FH, Kloppenborg PW.
    J Clin Endocrinol Metab; 1995 Oct 15; 80(10):2859-65. PubMed ID: 7559865
    [Abstract] [Full Text] [Related]

  • 5. The effect of clodronate and antioestrogens on bone loss associated with oestrogen withdrawal in postmenopausal women with breast cancer.
    Saarto T, Vehmanen L, Elomaa I, Välimäki M, Mäkelä P, Blomqvist C.
    Br J Cancer; 2001 Apr 20; 84(8):1047-51. PubMed ID: 11308252
    [Abstract] [Full Text] [Related]

  • 6. Influence of adjuvant tamoxifen treatment on bone mineral density and bone turnover markers in postmenopausal breast cancer patients in Japan.
    Yoneda K, Tanji Y, Ikeda N, Miyoshi Y, Taguchi T, Tamaki Y, Noguchi S.
    Cancer Lett; 2002 Dec 05; 186(2):223-30. PubMed ID: 12213292
    [Abstract] [Full Text] [Related]

  • 7. Effects of exemestane, anastrozole and tamoxifen on bone mineral density and bone turnover markers in postmenopausal early breast cancer patients: results of N-SAS BC 04, the TEAM Japan substudy.
    Aihara T, Suemasu K, Takei H, Hozumi Y, Takehara M, Saito T, Ohsumi S, Masuda N, Ohashi Y.
    Oncology; 2010 Dec 05; 79(5-6):376-81. PubMed ID: 21430407
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. A prospective study of bone loss and turnover after cardiac transplantation: effect of calcium supplementation with or without calcitonin.
    Välimäki MJ, Kinnunen K, Tähtelä R, Löyttyniemi E, Laitinen K, Mäkelä P, Keto P, Nieminen M.
    Osteoporos Int; 1999 Dec 05; 10(2):128-36. PubMed ID: 10501793
    [Abstract] [Full Text] [Related]

  • 10. Effects of toremifene and anastrozole on serum lipids and bone metabolism in postmenopausal females with estrogen receptor-positive breast cancer: the results of a 2-year multicenter open randomized study.
    Anan K, Mitsuyama S, Yanagita Y, Kimura M, Doihara H, Komaki K, Kusama M, Ikeda T.
    Breast Cancer Res Treat; 2011 Aug 05; 128(3):775-81. PubMed ID: 21638048
    [Abstract] [Full Text] [Related]

  • 11. Effect of an aromatase inhibitor on bmd and bone turnover markers: 2-year results of the Anastrozole, Tamoxifen, Alone or in Combination (ATAC) trial (18233230).
    Eastell R, Hannon RA, Cuzick J, Dowsett M, Clack G, Adams JE, ATAC Trialists' group.
    J Bone Miner Res; 2006 Aug 05; 21(8):1215-23. PubMed ID: 16869719
    [Abstract] [Full Text] [Related]

  • 12. Antiatherogenic effects of adjuvant antiestrogens: a randomized trial comparing the effects of tamoxifen and toremifene on plasma lipid levels in postmenopausal women with node-positive breast cancer.
    Saarto T, Blomqvist C, Ehnholm C, Taskinen MR, Elomaa I.
    J Clin Oncol; 1996 Feb 05; 14(2):429-33. PubMed ID: 8636753
    [Abstract] [Full Text] [Related]

  • 13. Serum lipid and bone metabolism effects of Toremifene vs. Letrozole as adjuvant therapy for postmenopausal early breast cancer patients: results of a multicenter open randomized study.
    Shien T, Doihara H, Sato N, Anan K, Komaki K, Miyauchi K, Yanagita Y, Fujisawa T, Mitsuyama S, Kanbayashi C, Kusama M, Kimura M, Jinno H, Sano M, Ikeda T.
    Cancer Chemother Pharmacol; 2018 Feb 05; 81(2):269-275. PubMed ID: 29196963
    [Abstract] [Full Text] [Related]

  • 14. The predictive value of biochemical markers of bone turnover for bone mineral density in early postmenopausal women treated with hormone replacement or calcium supplementation.
    Rosen CJ, Chesnut CH, Mallinak NJ.
    J Clin Endocrinol Metab; 1997 Jun 05; 82(6):1904-10. PubMed ID: 9177404
    [Abstract] [Full Text] [Related]

  • 15. Effects of suppression of estrogen action by the p450 aromatase inhibitor letrozole on bone mineral density and bone turnover in pubertal boys.
    Wickman S, Kajantie E, Dunkel L.
    J Clin Endocrinol Metab; 2003 Aug 05; 88(8):3785-93. PubMed ID: 12915670
    [Abstract] [Full Text] [Related]

  • 16. Effects of tamoxifen on bone mineral density and metabolism in postmenopausal women with early-stage breast cancer.
    Zidan J, Keidar Z, Basher W, Israel O.
    Med Oncol; 2004 Aug 05; 21(2):117-21. PubMed ID: 15299183
    [Abstract] [Full Text] [Related]

  • 17. Longitudinal changes in bone mineral density and bone turnover in postmenopausal women with primary hyperparathyroidism.
    Guo CY, Thomas WE, al-Dehaimi AW, Assiri AM, Eastell R.
    J Clin Endocrinol Metab; 1996 Oct 05; 81(10):3487-91. PubMed ID: 8855790
    [Abstract] [Full Text] [Related]

  • 18. Effect of letrozole versus placebo on bone mineral density in women with primary breast cancer completing 5 or more years of adjuvant tamoxifen: a companion study to NCIC CTG MA.17.
    Perez EA, Josse RG, Pritchard KI, Ingle JN, Martino S, Findlay BP, Shenkier TN, Tozer RG, Palmer MJ, Shepherd LE, Liu S, Tu D, Goss PE.
    J Clin Oncol; 2006 Aug 01; 24(22):3629-35. PubMed ID: 16822845
    [Abstract] [Full Text] [Related]

  • 19. The relationship of biochemical markers of bone turnover to bone density changes in postmenopausal women: results from the Postmenopausal Estrogen/Progestin Interventions (PEPI) trial.
    Marcus R, Holloway L, Wells B, Greendale G, James MK, Wasilauskas C, Kelaghan J.
    J Bone Miner Res; 1999 Sep 01; 14(9):1583-95. PubMed ID: 10469288
    [Abstract] [Full Text] [Related]

  • 20. Effect of tamoxifen on lumbar spine bone mineral density in postmenopausal women after 5 years.
    Love RR, Barden HS, Mazess RB, Epstein S, Chappell RJ.
    Arch Intern Med; 1994 Nov 28; 154(22):2585-8. PubMed ID: 7979855
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.